Enhanced Cancer Cell Specificity Through Combined Blue Light Therapy and Starvation Strategies

Area of Science:

• Oncology
• Biomedical Research
• Cancer Therapy

Background:

• Cancer remains a leading cause of mortality worldwide, necessitating novel therapeutic strategies.
• Current treatments often have significant side effects due to a lack of specificity.
• Targeting cancer cell metabolism and signaling pathways offers a promising avenue for selective cancer treatment.

Purpose of the Study:

• To investigate the synergistic effects of short-term starvation (STS) and blue light illumination therapy on various cancer types.
• To evaluate the selectivity of this combined treatment against cancerous versus normal cell lines.
• To elucidate the molecular mechanisms underlying the anti-cancer effects of the combined therapy.

Main Methods:

• Animal models of osteosarcoma, cervical, breast, liver carcinoma, and melanoma were used.
• Comparative in vitro analysis of cancerous (HeLa, 143B, MDA-MB-231, HepG2) and normal (NCM460, HEKa, L-O2) cell lines.
• Assessment of cellular signaling pathways (JNK, p38, p53, H2AX) and cellular damage (mitochondrial, nuclear) post-treatment.

Main Results:

• The combination of STS and blue light illumination demonstrated effectiveness in delaying cancer progression across multiple cancer models.
• The treatment exhibited significant cytotoxicity towards cancer cells while largely sparing normal cells, indicating high selectivity.
• In HeLa cells, the combination therapy activated JNK and p38 signaling, leading to p53 and H2AX activation, inducing mitochondrial and nuclear damage, and resulting in tumor cell death.
• Metabolic disorders were induced in tumor cells, disrupting biomolecule availability and contributing to selective lethality.

Conclusions:

• The combination of short-term starvation and blue light illumination therapy presents a promising and selective strategy for cancer treatment.
• This approach induces cancer cell death through dual mechanisms: activation of stress signaling pathways and disruption of cellular metabolism.
• Further research into this combined therapy could lead to novel, effective cancer elimination strategies.